Biblio
Reduced-toxicity conditioning regimen with busulfan, fludarabine, rATG, and 400 cGy TBI in pediatric patients undergoing hematopoietic stem cell transplant for high-risk hematologic malignancies. Pediatr Blood Cancer. 2021:e29087.
. Pediatric vulvovaginal graft-versus-host disease: A retrospective cohort study and literature review. J Pediatr Adolesc Gynecol. 2022.
. Impact of Hospital Acquired Infections on Post-Transplant One Year Mortality in Pediatric Bone Marrow Transplant Patients. Am J Infect Control. 2020.
. Immune Reconstitution and Infection Patterns Following Early Alemtuzumab and Reduced Intensity Transplantation for Non-Malignant Disorders in Pediatric Patients. Biol Blood Marrow Transplant. 2018.
Granulocyte Colony-Stimulating Factor is Safe and Well Tolerated following Allogeneic Transplantation in Patients with Sickle Cell Disease. Transplant Cell Ther. 2021.
.